Early-phase ARDS Non-Survivor Ontology Groups and Associated Proteins.

Figshare2015-12-02 更新2026-04-29 收录

数据链接：

https://figshare.com/articles/dataset/_Early_phase_ARDS_Non_Survivor_Ontology_Groups_and_Associated_Proteins_/1196145 数据链接链接失效反馈

官方服务：

资源简介：

Early-phase ARDS Non-Survivor Ontology Groups and Associated Proteins.

创建时间：

2015-12-02

Determination of Variation Parameters as a Crucial Step in Designing TMT-Based Clinical Proteomics Experiments

临床蛋白质组学

TMT定量分析

In quantitative shotgun proteomic analyses by liquid chromatography and mass spectrometry, a rigid study design is necessary in order to obtain statistically relevant results. Hypothesis testing, samp

NIAID Data Ecosystem30

Candidate proteomic biomarkers for non-alcoholic fatty liver disease (steatosis and non-alcoholic steatohepatitis) discovered with mass-spectrometry: a systematic review

非酒精性脂肪肝生物标志物

临床蛋白质组学

Context: Non-alcoholic fatty liver disease (NAFLD) is characterized by lipid accumulation in the liver which is accompanied by a series of metabolic deregulations. There are sustained research efforts

NIAID Data Ecosystem20

Data for manuscript, "An optimized workflow for MS-based quantitative proteomics of challenging clinical bronchoalveolar lavage fluid (BALF) samples"

临床蛋白质组学

肺部疾病生物标志物发现

Clinical BALF samples are rich in biomolecules, including proteins, and useful for molecular studies of lung health and disease. However, MS based proteomic analysis of BALF is impeded by the dynamic

Zenodo2023-03-02 更新00

Data-independent acquisition mass spectrometry to quantify protein levels in FFPE tumor biopsies for molecular diagnostics

临床蛋白质组学

肿瘤分子分型

Mass spectrometry-based protein quantitation is currently used to measure therapeutically relevant protein biomarkers in CAP/CLIA setting to predict likely responses of known therapies. Selected react

NIAID Data Ecosystem20

Supplemantal tables for "A Non-targeted Proteomics Newborn Screening Platform for Genetic Disorders".

遗传病筛查

临床蛋白质组学

Table S1 (List of proteins identified in DBS samples analyzed in the study). The list includes identified proteins with peptide and protein false discovery rates < 1%. Proteins shown in black are tho

Zenodo2024-10-04 更新20

Early-phase ARDS Non-Survivor Ontology Groups and Associated Proteins.

资源简介：

相关数据集